A retrospective review of the persistence of bDMARDs prescribed for the treatment of rheumatoid arthritis in the Australian population.

Authors: Graeme Jones, Stephen Hall, Paul Bird, Geoff Littlejohn, Kathleen Tymms, Peter Youssef, Eric Chung, Rina Barrett, Peter Button
International Journal of Rheumatic Diseases 2018; 21: 1581–1590

Related articles

Real world use of antipsychotic medication

A recent publication using Prospections real world data analytics shows, 1 in 5 Australian patients with schizophrenia [1], is medicated with older typical long acting injectable (LAI) antipsychotics. With schizophrenia being one of the ...

Are high coronary risk patients missing ou...

To examine whether high coronary risk patients in Australia, where use of lipid-lowering drugs (LLD) is very high by international standards, are receiving LLD.

Patterns of Antipsychotic Medication Presc...

Schizophrenia is a mental health disorder characterised by hallucinations, delusions and disorganised behaviour. The Australian pharmaceutical benefits scheme (PBS) reimburse a number of antipsychotic therapies, however, there is little...
This site is registered on wpml.org as a development site.